Cargando…

Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1

The squamous cell carcinoma antigen (SCC Ag) is a tumour-associated protein and a member of theserineproteaseinhibitor (serpin) family. The SCC Ag has been used as a serologic tumour marker for SCC progression, and its elevated serum levels are a risk factor for disease relapse. However, the biologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suminami, Y, Nagashima, S, Vujanovic, N L, Hirabayashi, K, Kato, H, Whiteside, T L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374407/ https://www.ncbi.nlm.nih.gov/pubmed/10732775 http://dx.doi.org/10.1054/bjoc.1999.1028

Ejemplares similares

Squamous cell carcinoma antigen suppresses radiation-induced cell death
por: Murakami, A, et al.
Publicado: (2001)

MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
por: Walter, W, et al.
Publicado: (2000)

Plasminogen activator inhibitor 1 may promote tumour growth through inhibition of apoptosis
por: Kwaan, H C, et al.
Publicado: (2000)

Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumour-infiltrating cells, and liver damage but accelerates tumour formation in nude mice
por: Chio, C-C, et al.
Publicado: (2001)

Detection of lymph node metastasis of oesophageal cancer by RT-nested PCR for SCC antigen gene mRNA
por: Kano, M, et al.
Publicado: (2000)

Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours
por: Green, J, et al.
Publicado: (2006)

Ceramide triggers p53-dependent apoptosis in genetically defined fibrosarcoma tumour cells
por: Pruschy, M, et al.
Publicado: (1999)

Microsatellite instability in thyroid tumours and tumour-like lesions
por: Lazzereschi, D, et al.
Publicado: (1999)

Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue
por: Lilge, L, et al.
Publicado: (2000)

Pretreatment apoptosis in carcinoma of the cervix correlates with changes in tumour oxygenation during radiotherapy
por: Sheridan, M T, et al.
Publicado: (2000)

Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells
por: Marko, D, et al.
Publicado: (2001)

Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity
por: Bennewith, K L, et al.
Publicado: (2001)

EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells
por: Jung, Y D, et al.
Publicado: (2001)

Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions
por: de Wilt, J H W, et al.
Publicado: (2000)

Influence of tumour size on uptake of(111)In-DTPA-labelled pegylated liposomes in a human tumour xenograft model
por: Harrington, K J, et al.
Publicado: (2000)

Characterization and distribution of an oncofetal antigen (M2A antigen) expressed on testicular germ cell tumours
por: Marks, A, et al.
Publicado: (1999)

Tumour cells engineered to secrete interleukin-15 augment anti-tumour immune responses in vivo
por: Hazama, S, et al.
Publicado: (1999)

Tumour-derived exosomes or microvesicles: another mechanism of tumour escape from the host immune system?
por: Whiteside, T L
Publicado: (2005)

Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis
por: Laube, F, et al.
Publicado: (2001)

An orthotopic xenograft model of human nonseminomatous germ cell tumour
por: Douglas, M L, et al.
Publicado: (2001)

Apoptosis in human tumours
por: Rubio, C A
Publicado: (2002)

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer
por: Shou, Y, et al.
Publicado: (2001)

Thalidomide increases both intra-tumoural tumour necrosis factor-α production and anti-tumour activity in response to 5,6-dimethylxanthenone-4-acetic acid
por: Cao, Z, et al.
Publicado: (1999)

Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma
por: Johansson, M, et al.
Publicado: (2000)

Characterization of antigen-presenting properties of tumour cells using virus-specific cytotoxic T lymphocytes
por: Spierings, D C J, et al.
Publicado: (2000)

Assessment of apoptosis in human breast tissue using an antibody against the active form of caspase 3: relation to tumour histopathological characteristics
por: Hadjiloucas, I, et al.
Publicado: (2001)

Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA
por: Watson, S A, et al.
Publicado: (1999)

Risk factors for testicular germ cell tumours by histological tumour type
por: Coupland, C A C, et al.
Publicado: (1999)

In vivo isolated kidney perfusion with tumour necrosis factor α (TNF-α) in tumour-bearing rats
por: Veen, A H van der, et al.
Publicado: (1999)

The contribution of DNA ploidy to radiation sensitivity in human tumour cell lines
por: Schwartz, J L, et al.
Publicado: (1999)

Epithelial tumours of the thymus
por: Ruffié, P, et al.
Publicado: (2001)

Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours
por: Jungbluth, A A, et al.
Publicado: (2000)

Labelling indices in human tumours: to apply corrections or not – that is the question
por: Bergström, C, et al.
Publicado: (1999)

Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours
por: Nakagawa, Y, et al.
Publicado: (1999)

Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor
por: Albo, D, et al.
Publicado: (2000)

Alteration of p16 and p15 genes in human uterine tumours
por: Nakashima, R, et al.
Publicado: (1999)

Induction of haem oxygenase-1 by nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth
por: Doi, K, et al.
Publicado: (1999)

CD55 is over-expressed in the tumour environment
por: Li, L, et al.
Publicado: (2001)

A novel charged trinuclear platinum complex effective against cisplatin-resistant tumours: hypersensitivity of p53-mutant human tumour xenografts
por: Pratesi, G, et al.
Publicado: (1999)

Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumour cells
por: Barthelmes, H U, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_b99a4kbes4p98sfjp6d6rstf38